Mindblown: a blog about philosophy.
-

ADI Just Crossed $4 Billion In Revenue But The Stock Is Sitting Below $400
ADI just topped $4 billion in quarterly revenue, while its AI infrastructure opportunity could be much larger than investors realize.
-

Target’s Turnaround Is Finally Being Measured in Footsteps
Target’s latest quarter suggests its turnaround is gaining traction as shoppers return, sales broaden, and TGT stock climbs above key moving averages.
-

Bitcoin Surges Above $70,000 as Trump Pushes Crypto Bill
Trump is pushing Congress to advance the CLARITY Act, potentially giving Bitcoin and crypto markets a major boost through clearer U.S. rules.
-

Walmart Raises Its Outlook, but U.S. Sales Slow
Walmart raised its forecast after strong earnings, but weaker U.S. sales could signal that financially pressured consumers are starting to pull back.
-

Lowe’s Stock Climbs Despite Mixed Q2 Earnings, Investors Aren’t Worried
Investors may believe the worst is priced into Lowe’s – a company that offers a historic mix of capital gains and shareholder value.
-

Norwegian Cruise Line (NCLH) Stock’s Downtrodden Ship Could Right Itself
Although NCLH stock is currently a weak name, such turmoil has historically been viewed as a discounted opportunity.
-

SK Hynix to Spend $28.7 Billion on Buybacks
SK Hynix is betting $28.7 billion on its own stock as AI chip demand surges, but investors still face risks from the semiconductor cycle.
-

Investigating Home Depot’s Best Quarter Since 2022 Amidst Housing Crisis
Home Depot beats expectations with its strongest comparable-sales growth since 2022, even as housing remains stuck in a prolonged downturn.
-

Target Shows Signs Its Turnaround Is Working
Target’s turnaround is gaining momentum as sales beat expectations, digital growth accelerates and the retailer raises its full-year outlook.
-

Merck and Moderna’s Cancer Vaccine Shows Substantial Promise
Moderna and Merck’s personalized cancer vaccine shows promising melanoma results, potentially opening a new era of targeted cancer treatment.
Got any book recommendations?